Table 1.
Subjects’ clinical and metabolic characteristics
| HC (n = 20) | Type 1 diabetes (n = 29) | p-value | |
|---|---|---|---|
| Age (years) | 46.5 ± 11.7 | 47.2 ± 12.7 | 0.8 |
| BMI (kg/m2) | 26.0 ± 4.5 | 28.4 ± 6.7 | 0.3 |
| Gender (M/F) n | 9/11 | 14/15 | – |
| HbA1c (mmol/mol) | 35.1 ± 2.8 | 57.3 ± 7.6 | < 0.001*** |
| HbA1c (%) | 5.4 ± 0.3 | 7.4 ± 0.7 | < 0.001*** |
| Glucose (mmol/L) | 4.8 ± 1.0 | 9.7 ± 3.7 | < 0.001*** |
| CD34+ CD133+ per 100 lymphocytes | 0.09 ± 0.03 | 0.02 ± 0.01 | < 0.001*** |
| Fibronectin adhesion assay per hpf | 68.6 ± 34.5 | 33.9 ± 14.7 | 0.01* |
Body mass index (BMI), male (M), female (F), high power field (hpf). *p < 0.05, ** p < 0.01, ***p < 0.001